Increased Risk for Congenital Heart Defects in Children Carrying the ABCB1 Gene C3435T Polymorphism and Maternal Periconceptional Toxicants Exposure

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Wang, Chuan ^a,c,d   Xie, Liang ^b,d   Zhou, Kaiyu ^a,d   Zhan, Yalan ^a,c   Li, Yifei ^a,c   Li, Huaying ^a,c   Qiao, Lina ^a   Wang, Fang ^a   Hua, Yimin ^a,b,d  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

^d BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLPHENOL; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PHTHALIC ACID; RNA;

ABCB1 GENE; ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHILD; CHINESE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECTOPIC PREGNANCY; FEMALE; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HEART SEPTUM DEFECT; HUMAN; INCIDENCE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PERINATAL DRUG EXPOSURE; PLACENTA; PRESCHOOL CHILD; PROTEIN EXPRESSION; RNA TRANSLATION; SEQUENCE ANALYSIS; SPONTANEOUS ABORTION; STILLBIRTH; STRUCTURED QUESTIONNAIRE; UMBILICAL CORD;

BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CHINA; DNA PRIMERS; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; MATERNAL EXPOSURE; P-GLYCOPROTEIN; PHENOLS; PHTHALIC ACIDS; POLYMORPHISM, GENETIC; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TERATOGENS;

EID: 84880439115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068807     Document Type: Article

References (39)

1. Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, et al. (2007) Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 3015-3038.
2. Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, et al. (2007) Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 2995-3014.
3. Lupo PJ, Symanski E, Langlois PH, Lawson CC, Malik S, et al. (2012) Maternal occupational exposure to polycyclic aromatic hydrocarbons and congenital heart defects among offspring in the national birth defects prevention study. Birth Defects Res A Clin Mol Teratol 94: 875-881.
4. Gilboa SM, Desrosiers TA, Lawson C, Lupo PJ, Riehle-Colarusso TJ, et al. (2012) Association between maternal occupational exposure to organic solvents and congenital heart defects, National Birth Defects Prevention Study, 1997-2002. Occup Environ Med 69: 628-635.
5. Thulstrup AM, Bonde JP, (2006) Maternal occupational exposure and risk of specific birth defects. Occup Med (Lond) 56: 532-543.
6. Hanke W, Jurewicz J, (2004) The risk of adverse reproductive and developmental disorders due to occupational pesticide exposure: an overview of current epidemiological evidence. Int J Occup Med Environ Health 17: 223-243.
7. Iqbal M, Audette MC, Petropoulos S, Gibb W, Matthews SG, (2012) Placental drug transporters and their role in fetal protection. Placenta 33: 137-142.
8. Ni Z, Mao Q, (2011) ATP-binding cassette efflux transporters in human placenta. Curr Pharm Biotechnol 12: 674-685.
9. Prouillac C, Lecoeur S, (2010) The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies. Drug Metab Dispos 38: 1623-1635.
10. Vahakangas K, Myllynen P, (2009) Drug transporters in the human blood-placental barrier. Br J Pharmacol 158: 665-678.
11. Myllynen P, Immonen E, Kummu M, Vahakangas K, (2009) Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol 5: 1483-1499.
12. Myllynen P, Pasanen M, Pelkonen O, (2005) Human placenta: a human organ for developmental toxicology research and biomonitoring. Placenta 26: 361-371.
13. Myren M, Mose T, Mathiesen L, Knudsen LE, (2007) The human placenta-an alternative for studying foetal exposure. Toxicol In Vitro 21: 1332-1340.
14. Ceckova-Novotna M, Pavek P, Staud F, (2006) P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod Toxicol 22: 400-410.
15. Rawles LA, Acuna D, Erickson RP, (2007) The role of multiple drug resistance proteins in fetal and/or placental protection against teratogen-induced orofacial clefting. Mol Reprod Dev 74: 1483-1489.
16. Atkinson DE, Brice-Bennett S, D'Souza SW, (2007) Antiepileptic medication during pregnancy: does fetal genotype affect outcome? Pediatr Res 62: 120-127.
17. Abu-Qare AW, Elmasry E, Abou-Donia MB, (2003) A role for P-glycoprotein in environmental toxicology. J Toxicol Environ Health B Crit Rev 6: 279-288.
18. Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, Schinkel AH, (1999) Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 104: 1441-1447.
19. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, et al. (2006) Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27: 602-609.
20. Mathias AA, Hitti J, Unadkat JD, (2005) P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 289: R963-969.
21. Gil S, Saura R, Forestier F, Farinotti R, (2005) P-glycoprotein expression of the human placenta during pregnancy. Placenta 26: 268-270.
22. Hutson JR, Koren G, Matthews SG, (2010) Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology. Placenta 31: 351-357.
23. Hemauer SJ, Nanovskaya TN, Abdel-Rahman SZ, Patrikeeva SL, Hankins GD, et al. (2010) Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. Biochem Pharmacol 79: 921-925.
24. Van Tongeren M, Nieuwenhuijsen MJ, Gardiner K, Armstrong B, Vrijheid M, et al. (2002) A job-exposure matrix for potential endocrine-disrupting chemicals developed for a study into the association between maternal occupational exposure and hypospadias. Ann Occup Hyg 46: 465-477.
25. Brouwers MM, van Tongeren M, Hirst AA, Bretveld RW, Roeleveld N, (2009) Occupational exposure to potential endocrine disruptors: further development of a job exposure matrix. Occup Environ Med 66: 607-614.
26. Pei XQ, Song M, Guo M, (2013) Concentration and risk assessment of phthalates present in indoor air from newly decorated apartments. Atmospheric Environment 68: 17-23.
27. Saito I, Onuki A, Seto H, (2004) Indoor air pollution by alkylphenols in Tokyo. Indoor Air 14: 325-332.
28. Zhou B, (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi 23: 5-10.
29. Liu Y, Tong G, Tong W, Lu L, Qin X, (2011) Can body mass index, waist circumference, waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in Chinese subjects? BMC Public Health 11: 35.
30. Garcia-Closas M, Lubin JH, (1999) Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am J Epidemiol 149: 689-692.
31. Bliek BJ, van Schaik RH, van der Heiden IP, Sayed-Tabatabaei FA, van Duijn CM, et al. (2009) Maternal medication use, carriership of the ABCB1 3435C>T polymorphism and the risk of a child with cleft lip with or without cleft palate. Am J Med Genet A 149A: 2088-2092.
32. Martinelli M, Carinci F, Morselli PG, Palmieri A, Girardi A, et al. (2011) Study of ABCB1 multidrug resistance protein in a common orofacial malformation. Int J Immunopathol Pharmacol 24: 1-5.
33. Rahi M, Heikkinen T, Hakkola J, Hakala K, Wallerman O, et al. (2008) Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta. Hum Exp Toxicol 27: 65-71.
34. Nugteren JJ, Snijder CA, Hofman A, Jaddoe VW, Steegers EA, et al. (2012) Work-related maternal risk factors and the risk of pregnancy induced hypertension and preeclampsia during pregnancy. The Generation R Study. PLoS One 7: e39263.
35. Burdorf A, Brand T, Jaddoe VW, Hofman A, Mackenbach JP, et al. (2011) The effects of work-related maternal risk factors on time to pregnancy, preterm birth and birth weight: the Generation R Study. Occup Environ Med 68: 197-204.
36. Pierik FH, Burdorf A, Deddens JA, Juttmann RE, Weber RF, (2004) Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environ Health Perspect 112: 1570-1576.
37. Colabufo NA, Berardi F, Perrone MG, Capparelli E, Cantore M, et al. (2010) Substrates, inhibitors and activators of P-glycoprotein: candidates for radiolabeling and imaging perspectives. Curr Top Med Chem 10: 1703-1714.
38. Molsa M, Heikkinen T, Hakkola J, Hakala K, Wallerman O, et al. (2005) Functional role of P-glycoprotein in the human blood-placental barrier. Clin Pharmacol Ther 78: 123-131.
39. Kishi R, Sata F, Yoshioka E, Ban S, Sasaki S, et al. (2008) Exploiting gene-environment interaction to detect adverse health effects of environmental chemicals on the next generation. Basic Clin Pharmacol Toxicol 102: 191-203.